%0 Journal Article %T Reply to comment on: ˇ°Advantages of bevacizumab for aggressive posterior retinopathy of prematurityˇ± %A Michael J. Shapiro %A Michael P. Blair %A Sarah Hilkert Rodriguez %A Sidney A. Schechet %J Archive of "Taiwan Journal of Ophthalmology". %D 2019 %R 10.4103/tjo.tjo_10_19 %X We would like to thank Dr. Samanta for interest in our recent manuscript regarding aggressive posterior retinopathy of prematurity (APROP).[1 %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557064/